Data Sinergitama Jaya Tbk. vs Merck Tbk. — how do they compare? Data Sinergitama Jaya Tbk. trades at Rp169 (market cap 345.38B, 663.7K 24h volume), while Merck Tbk. trades at Rp3,830 (market cap 1.7T, 13.3K 24h volume). The key difference: Merck Tbk. is far larger — about 4.9× Data Sinergitama Jaya Tbk.'s market cap, and Data Sinergitama Jaya Tbk. is more actively traded (663.7K versus 13.3K). Which is the better fit depends on your goals.
| ELIT | MERK | |
|---|---|---|
Market Cap | 345.38B | 1.7T |
Volume | 663.7K | 13.3K |
Lot | 6.64K | 133 |
Turnover | 113.78M | 50.92M |
Average Price | 171.43 | 3,828.42 |
Value | 113.78M | 50.92M |
Indicative Equilibrium Price | 174 | 3,850 |
Indicative Equilibrium Volume | 2.63K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Data Sinergitama Jaya Tbk (the “Company”) was established based on Notarial Deed No. 38dated June 20, 2011 of Dana Sasmita, S.H., notary in Jakarta. The Company’s immediate and ultimate holding company is PT Gratus Deo Indonesia, a company incorporated in Indonesia.
Read more on ELIT →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →